Pulmonary function, diffusing capacity, and forced oscillometry after recovery from COVID-19 in young, healthy, recreationally active men and women
- PMID: 40547507
- PMCID: PMC12181006
- DOI: 10.1016/j.ijregi.2025.100668
Pulmonary function, diffusing capacity, and forced oscillometry after recovery from COVID-19 in young, healthy, recreationally active men and women
Abstract
Objectives: This study aimed to examine the long-term impact of COVID-19 on pulmonary function (spirometry and forced oscillometry technique, and lung diffusing capacity for carbon monoxide [DLCO]) in a large group of young, recreationally active adults.
Methods: A total of 71 participants (aged 21 years) who had recovered from a positive COVID-19 infection (COVID+) and 55 participants (aged 24 years) who had never tested positive for COVID-19 (COVID-) performed routine spirometry and DLCO. Some patients also completed forced oscillometry technique (n = 22 COVID+; n = 18 COVID-).
Results: The ratio of forced expiratory volume in 1 second to forced vital capacity (FEV1/FVC) and forced expiratory flow between 25% and 75% of FVC (FEF25-75%) were slightly but significantly lower in patients who were COVID+ than those who were COVID- (FEV1/FVC = 93.6 ± 8.3 vs 96.9 ± 6.7%-predicted, P = 0.019; FEF25-75% = 86.0 ± 21.2 vs 94.5 ± 21.1%-predicted, P = 0.015, respectively). There were no associations between any pulmonary function variables or DLCO and the number of days between COVID-19 infection and testing.
Conclusions: Our findings provide evidence that pulmonary function and DLCO are largely preserved after recovery from mild COVID-19 in young, healthy, active men and women.
Keywords: COVID19; Forced oscillation testing; Lung diffusing capacity; Lung function tests; Spirometry.
© 2025 The Authors.
Conflict of interest statement
The author have no competing interests to declare.
Figures

Similar articles
-
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2. Cochrane Database Syst Rev. 2018. PMID: 29297205 Free PMC article.
-
Lung function at 16-19 years in males and females born very prematurely.Pediatr Pulmonol. 2023 Jul;58(7):2035-2041. doi: 10.1002/ppul.26428. Epub 2023 May 5. Pediatr Pulmonol. 2023. PMID: 37144861
-
Nebulised hypertonic saline for cystic fibrosis.Cochrane Database Syst Rev. 2018 Sep 27;9(9):CD001506. doi: 10.1002/14651858.CD001506.pub4. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2023 Jun 14;6:CD001506. doi: 10.1002/14651858.CD001506.pub5. PMID: 30260472 Free PMC article. Updated.
-
Exercise versus airway clearance techniques for people with cystic fibrosis.Cochrane Database Syst Rev. 2022 Jun 22;6(6):CD013285. doi: 10.1002/14651858.CD013285.pub2. Cochrane Database Syst Rev. 2022. PMID: 35731672 Free PMC article.
-
Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline.Cochrane Database Syst Rev. 2021 Dec 1;12(12):CD013720. doi: 10.1002/14651858.CD013720.pub3. Cochrane Database Syst Rev. 2021. PMID: 34850383 Free PMC article.
References
-
- Centers for Disease Control and Prevention . 2025. Demographic trends of COVID-19 cases and deaths in the US reported to CDC.https://covid.cdc.gov/covid-data-tracker/#demographics [accessed 01 August 2023]
-
- Widmann M., Gaidai R., Schubert I., Grummt M., Bensen L., Kerling A., et al. COVID-19 in female and male athletes: symptoms, clinical findings, outcome, and prolonged exercise intolerance-A prospective, observational, multicenter cohort study (CoSmo-S) Sports Med. 2024;54:1033–1049. doi: 10.1007/s40279-023-01976-0. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources